Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spiros

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bulletin of Mathematical Biology|April 29, 1998
Testing a model for the dynamics of actin structures with biological parameter valuesA Spiros, L Edelstein-Keshet
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
A quantitative system pharmacology computer model for cognitive deficits in schizophreniaH Geerts, P Roberts, A Spiros
Journal of Neural Transmission. Supplementum|November 29, 2002
Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapyH Geerts, L Finkel, R Carr, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Has the time come for predictive computer modeling in CNS drug discovery and development?H Geerts, A Spiros, P Roberts, et al.
Journal of Mathematical Biology|October 3, 2003
Mutual interactions, potentials, and individual distance in a social aggregationA Mogilner, L Edelstein-Keshet, L Bent, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2014
Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology ModelJ Liu, A Ogden, T A Comery, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bulletin of Mathematical Biology|April 29, 1998
Testing a model for the dynamics of actin structures with biological parameter valuesA Spiros, L Edelstein-Keshet
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
A quantitative system pharmacology computer model for cognitive deficits in schizophreniaH Geerts, P Roberts, A Spiros
Journal of Neural Transmission. Supplementum|November 29, 2002
Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapyH Geerts, L Finkel, R Carr, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Has the time come for predictive computer modeling in CNS drug discovery and development?H Geerts, A Spiros, P Roberts, et al.
Journal of Mathematical Biology|October 3, 2003
Mutual interactions, potentials, and individual distance in a social aggregationA Mogilner, L Edelstein-Keshet, L Bent, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2014
Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology ModelJ Liu, A Ogden, T A Comery, et al.
Pageof 1